Algorae Pharmaceuticals Limited

LVCLF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$469$307$3,108$622
Short-Term Investments$1,850$2,100$0$3,000
Receivables$4$22$29$0
Inventory$0$0$0$0
Other Curr. Assets$76$108$55$136
Total Curr. Assets$2,399$2,537$3,193$3,758
Property Plant & Equip (Net)$0$0$0$2
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$0$0$0$2
Other Assets$0$0$0$0
Total Assets$2,399$2,537$3,193$3,760
Liabilities
Payables$69$137$117$111
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$101$8$62$29
Total Curr. Liab.$170$146$178$140
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$170$146$178$140
Equity
Pref Stock$0$0$0$0
Common Stock$81,541$81,541$81,541$81,528
Retained Earnings-$79,885-$79,735-$79,084-$78,559
AOCI$573$586$557$650
Other Equity$0$0$0$0
Total Equity$2,229$2,391$3,014$3,619
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$2,399$2,537$3,193$3,760
Net Debt-$469-$307-$3,108-$622